SARS CoV 2 News and Research

RSS

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants of the COVID-19 virus.

14 Jan 2022

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

A new study, posted to the bioRxiv* preprint server, has developed a single-cell atlas that presents the shared and distinct immune responses and metabolism following SARS-CoV-2 and HIV-1 infections.

13 Jan 2022

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

A recent study revealed the effectiveness of 93% for the BNT162b2 vaccine against COVID-19 hospitalization among adolescents (12 to 18 years). This study included 179 patients at 19 sites in 16 states. The same group of researchers have extended their analysis to 31 locations in 23 states across the U.S. and recruited 266 more patients who had been hospitalized with SARS-CoV-2 infection.

13 Jan 2022

COVID-19 vaccination breakthrough infections in a real-world setting

Researchers describe the pattern and characteristics of infections after COVID-19 vaccination.

13 Jan 2022

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Researchers conducted a detailed epitope mapping of Np and developed an experimental double antigen-based ELISA.

13 Jan 2022

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Researchers determine whether sequences within SARS-CoV-2 could lead to an immune response to autoantigens associated with autoimmune myocarditis.

13 Jan 2022

Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air

Researchers re-design HFM filters for removing/deactivating viral aerosols.

13 Jan 2022

Researchers identify gene variant that protects against severe COVID-19

An international metastudy led by researchers at Karolinska Institutet in Sweden has identified a specific gene variant that protects against severe COVID-19 infection.

13 Jan 2022

Analysis of COVID vaccine breakthrough infections in highly vaccinated Israel

Researchers evaluated and modeled age-structured cases of SARS-CoV-2 infection, SARS-CoV-2 vaccination coverage, and breakthrough infections.

13 Jan 2022

Assessing how autoantibodies in COVID-19 correlate with anti-viral humoral responses

Researchers screen several systemic autoantibodies to assess their association with the severity of COVID-19.

13 Jan 2022

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

Researchers test the durability of antibodies produced by a vaccine-induced full-length SARS-CoV-2 spike protein and receptor-binding domain.

13 Jan 2022

Harmful effects of SARS-CoV-2 infection in pregnant women and their newborns

Pregnant women should get vaccinated to minimize the detrimental health effects COVID-19 has on the placenta, the fetus and the newborn, states Roberta L. DeBiasi, M.D., M.S., division chief of Pediatric Infectious Diseases at Children's National Hospital in an editorial published in The Journal of Infectious Diseases.

13 Jan 2022

Researchers detect Delta variant in the blood and placentas of women who had pregnancy complications

A growing body of evidence has linked the Delta variant of SARS-CoV-2, the virus that causes COVID-19, with an increased risk for pregnancy complications, including stillbirths.

13 Jan 2022

Effect of emerging SARS-CoV-2 variants and vaccination status on COVID-19 transmission rates

In a new study, a team of researchers determined the impact of the emerging SARS-CoV-2 variants of concern and vaccination status on the SARS-CoV-2 transmission dynamics.

13 Jan 2022

Investigating the presence of human rRNA in the SARS-CoV-2 genome

In a new study, a team of researchers investigated the existence of SARS-CoV-2-host chimeric RNA and described two novel human-derived genomic insertions present in the circulating variants of SARS-CoV-2.

13 Jan 2022

Plasma SARS-CoV-2 viral RNA as a valuable biomarker for SARS-CoV-2 infection in the lungs

Researchers recently evaluated respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA (vRNA) levels in longitudinal samples collected simultaneously from mechanically ventilated coronavirus disease 2019 (COVID-19) patients and analyzed their connections and relationships with clinical outcomes.

13 Jan 2022

SARS CoV 2 News and Research

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

COVID-19 vaccination breakthrough infections in a real-world setting

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air

Researchers identify gene variant that protects against severe COVID-19

Analysis of COVID vaccine breakthrough infections in highly vaccinated Israel

Assessing how autoantibodies in COVID-19 correlate with anti-viral humoral responses

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

Harmful effects of SARS-CoV-2 infection in pregnant women and their newborns

Researchers detect Delta variant in the blood and placentas of women who had pregnancy complications

Effect of emerging SARS-CoV-2 variants and vaccination status on COVID-19 transmission rates

Investigating the presence of human rRNA in the SARS-CoV-2 genome

Plasma SARS-CoV-2 viral RNA as a valuable biomarker for SARS-CoV-2 infection in the lungs

Exploring the structural basis of antibody evasion and enhanced transmission of the SARS-CoV-2 Omicron variant

Microbial characteristics of COVID-19

Prevalence of persistent Long COVID symptoms after SARS-CoV-2 infection

Analyzing milk produced after maternal COVID-19 diagnosis for the presence of SARS-CoV-2

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News